{
  "id": [
    "33271945"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "33271945"
  ],
  "pmcid": [
    "PMC7760260"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7760260"
      ]
    }
  ],
  "doi": [
    "10.3390/biom10121625"
  ],
  "title": [
    "Recent Development of Aminoacyl-tRNA Synthetase Inhibitors for Human Diseases: A Future Perspective."
  ],
  "authorString": [
    "Kim SH, Bae S, Song M."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Kim SH"
          ],
          "firstName": [
            "Soong-Hyun"
          ],
          "lastName": [
            "Kim"
          ],
          "initials": [
            "SH"
          ],
          "authorId": [
            {
              "_": "0000-0002-6765-3693",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro Dong-gu, Daegu 41061, Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Bae S"
          ],
          "firstName": [
            "Seri"
          ],
          "lastName": [
            "Bae"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro Dong-gu, Daegu 41061, Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Song M"
          ],
          "firstName": [
            "Minsoo"
          ],
          "lastName": [
            "Song"
          ],
          "initials": [
            "M"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro Dong-gu, Daegu 41061, Korea."
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-6765-3693",
          "$": {
            "type": "orcid"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "12"
      ],
      "volume": [
        "10"
      ],
      "journalIssueId": [
        "3060687"
      ],
      "dateOfPublication": [
        "2020 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-12-01"
      ],
      "journal": [
        {
          "title": [
            "Biomolecules"
          ],
          "ISOAbbreviation": [
            "Biomolecules"
          ],
          "medlineAbbreviation": [
            "Biomolecules"
          ],
          "NLMid": [
            "101596414"
          ],
          "ISSN": [
            "2218-273X"
          ],
          "ESSN": [
            "2218-273X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "Aminoacyl-tRNA synthetases (ARSs) are essential enzymes that ligate amino acids to tRNAs and translate the genetic code during protein synthesis. Their function in pathogen-derived infectious diseases has been well established, which has led to the development of small molecule therapeutics. The applicability of ARS inhibitors for other human diseases, such as fibrosis, has recently been explored in the clinical setting. There are active studies to find small molecule therapeutics for cancers. Studies on central nervous system (CNS) disorders are burgeoning as well. In this regard, we present a concise analysis of the recent development of ARS inhibitors based on small molecules from the discovery research stage to clinical studies as well as a recent patent analysis from the medicinal chemistry point of view."
  ],
  "affiliation": [
    "New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro Dong-gu, Daegu 41061, Korea."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Research Support, Non-U.S. Gov't",
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "NRF-2017M3A9G4052951"
          ],
          "agency": [
            "National Research Foundation of Korea"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Aminoacyl-tRNA synthetase",
        "human diseases",
        "Small Molecule Inhibitors"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.3390/biom10121625"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7760260"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7760260?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "PPR233042"
          ],
          "source": [
            "PPR"
          ],
          "type": [
            "Preprint in"
          ],
          "note": [
            "CrossRef Pre-print loader"
          ],
          "orderIn": [
            "10002"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct",
        "pdb"
      ]
    }
  ],
  "dateOfCreation": [
    "2020-12-04"
  ],
  "firstIndexDate": [
    "2020-12-04"
  ],
  "fullTextReceivedDate": [
    "2020-12-28"
  ],
  "dateOfRevision": [
    "2021-01-29"
  ],
  "electronicPublicationDate": [
    "2020-12-01"
  ],
  "firstPublicationDate": [
    "2020-12-01"
  ]
}